The Clinton Herald, Clinton, Iowa

Community News Network

December 11, 2013

Personal genetic tests face sharper scrutiny after 23andMe

WASHINGTON — 23andMe Inc.'s clash with U.S. regulators over the direct sale of its gene analysis service to consumers signals stiffer oversight of thousands of tests in an industry predicted to increase fivefold in size.

The Personal Genome Test from Google-backed 23andMe gives individuals an analysis of their risk of hundreds of diseases based on DNA data. The Food and Drug Administration's action last month to ban sales of the service suggests the agency is expanding its focus to tests it hadn't regulated, said Jeff Gibbs, an attorney with Hyman Phelps & McNamara in Washington.

Genetic tests are in increasing demand to diagnose or determine disease risk and help make treatment decisions, especially in cancer. Increased regulation is needed to make sure tests like 23andMe's fulfill their claims, said James Evans, a geneticist at the University of North Carolina in Chapel Hill.

"These tests should ultimately have to prove themselves," Evans said in a telephone interview. "They should be forced to gather the evidence that backs up those claims."

Genetic analysis of sick and healthy individuals poses new challenges to insurers and government health programs such as Medicare that pay for medical care. UnitedHealth Group Inc., the biggest U.S. health insurer, said last year that it expects national annual spending on genetic tests to increase fivefold over the next decade to $25 billion.

The industry includes companies such as closely held San Diego-based Pathway Genomics Inc., which was cautioned by the FDA about giving estimates of genetic risk of disease directly to consumers, and now provides them through doctors. A large part of the industry isn't tightly overseen by the agency, including Salt Lake City-based Myriad Genetics Inc., among the biggest providers of genetic breast and ovarian cancer diagnostic services, and many smaller laboratories, such as closely held Ambry Genetics Corp., that offer a variety of genetic tests.

23andMe, based in Mountain View, Calif., said in a statement on its website that the company is committed to working with the FDA to address the agency's concerns. While all marketing of the Personal Genome stopped almost two weeks ago, and 23andMe halted sales of health-related data Dec. 5, some customers said the FDA is interfering with their access to personal health information.

"I want to know my own biology; it's my right," said Lynn Fellman, a multimedia artist in Washington who signed up two years ago with 23andMe. "With 23andMe, I don't have to go to the medical establishment to get this information."

Other clients say 23andMe misled them about the accuracy and validity of its test. A complaint filed Nov. 27 in federal court in San Diego seeks $5 million, saying the Personal Genome Service advertised medical claims without getting appropriate FDA authorization.

The FDA's wider purview may include laboratory developed tests, Gibbs said. These tests examine genes or groups of genes for signs of damage and dangerous inborn variations. Manufacturers typically seek FDA marketing clearance for tests that determine whether a person's cancer is treatable by a certain drug. For example, doctors prescribe skin cancer treatment with Roche Holding's Zelboraf after the patient undergoes an FDA-approved test for a certain mutation in the BRAF gene.

Many labs, however, have developed tests that aren't FDA- approved. Some of the more controversial tests use proprietary formulas to suggest whether cancer patients should receive certain treatments, such as harsher forms of radiation or chemotherapy. FDA Commissioner Margaret Hamburg said in June the agency is working to ensure the validity and accuracy of "'high-risk'' laboratory tests.

''It's an issue that's been percolating for years," Gibbs said in a telephone interview. "This is the policy issue that's most in people's minds."

There are about 3,000 laboratory-developed tests available, and most are monitored by the Centers for Medicare & Medicaid Services, rather than the FDA. CMS requires laboratories only show that the tests are accurate and repeatable, not that they contribute to patient care, as FDA reviews do.

The FDA is preparing guidance for regulating laboratory tests, which is currently in administrative review, Susan Laine, an agency spokeswoman, said in an email. Laine wouldn't say what further action the agency might take in the testing area.

The FDA last month gave its first approval for medical use of next-generation sequencing machines, which laboratories increasingly use to decipher swatches of DNA. One of the approved machines is a product from San Diego-based Illumina Inc., the biggest maker of sequencers, that helps laboratories develop tests for specific medical purposes.

23andMe's direct-to-consumer approach bears little resemblance to laboratory tests that are normally ordered and interpreted by physicians, said Alan Mertz, president of the American Clinical Laboratory Association, an industry group based in Washington.

The FDA doesn't have the authority to regulate laboratory tests, Mertz's group said in a citizen's petition in June. In addition, reining in laboratory tests would stand in the way of patient care, because gaining approval would be too expensive and laborious, the petition said.

The tests "will never generate the financial returns needed to justify the costs of obtaining FDA clearance or approval," the petition said. "Patients served by these tests would be left with no testing options."

1
Text Only
Community News Network
  • When your doctor commits suicide, things get complicated

    When they call for appointments, patients are told they can't see their doctor. Ever. The standard line: "We are sorry, but your doctor died suddenly."

    July 15, 2014

  • NWS-HB0713-HowardMartin-004.jpg Airman laid to rest back home in Indiana six decades after death

    The mystery of what happened to a military transport plane that disappeared in the fall of 1952 into an Alaskan glacier was solved two years ago when a helicopter crew spotted the wreckage. But it took another two years to retrieve the remains of Airman Howard Miller and 16 other servicemen passengers. Saturday, Miller was laid to rest in his hometown of Elwood, Ind., with full military honors. Hundreds turned out for the funeral and burial services.

    July 13, 2014 2 Photos

  • This is what happened when I drove my Mercedes to pick up food stamps

     I climbed the ladder quickly, free to work any hours in any location for any pay. I moved from market to market, always achieving a better title, a better salary. Succeeding.

    July 8, 2014

  • Nation's first soda tax could come to Berkeley

    The Berkeley City Council unanimously decided last week to put the 1-cent-per-ounce tax on the ballot this November. Approving the tax would mean a major defeat for the soda industry, which has spent millions to crush the effort nationwide.

    July 7, 2014

  • President Barack Obama mug Best president? Worst president? Don't read too much into those polls

    The questions about who are the best and worst post-WWII presidents are useless. What they mainly show is that Republicans are far more unified around a single story than are Democrats.

    July 2, 2014 1 Photo

  • What states can do on their own about immigration

    It's official: Congress won't take up immigration reform this year. This week, President Barack Obama said he'll use executive actions to change policies unilaterally.

    July 1, 2014

  • The Internet has changed how we curse

    Relatively recent technologies — cable television, satellite radio, and social media — provide us with a not-too-unrealistic picture of how often people swear in public and what they say when they do.

    June 24, 2014

  • May 2014 was the hottest may in recorded history

    According to new data released this week, May 2014 is officially the warmest May in recorded history.
    Both NASA and the Japan Meteorological Agency have tentatively ranked May at the top of historical measurements, though NASA's numbers are preliminary because crucial information is still missing from China.

    June 18, 2014

  • facebook.png Facebook making big changes to its advertisements

    Facebook is making significant changes to the advertisements on its network, and said Thursday that it will give users more control over which ads they see on its network.

    June 12, 2014 1 Photo

  • Avery Johnson.jpg Assault suspect loses college baseball scholarship

    The investigation into an alleged sexual assault at a alcohol-fueled post-prom party in Georgia has led to at least one suspect losing a college baseball scholarship.

    June 11, 2014 1 Photo

Front page
Clinton Herald Photos


Browse, buy and submit pictures with our photo site.

Poll

What are your plans for the weekend?

Enjoying the outdoors
Staying in out of the heat
Traveling
Other
     View Results
AP Video
Olympics 2014
Featured Comment
Featured Ads
Blue Zones Project
Parade
Magazine

Click HERE to read all your Parade favorites including Hollywood Wire, Celebrity interviews and photo galleries, Food recipes and cooking tips, Games and lots more.